Suchergebnisse - "Antibodies, Monoclonal, Humanized"

PubPharm (63)

1

Inhibition of the AURKA/YAP1 axis is a promising therapeutic option for overcoming cetuximab resistance in colorectal cancer stem cells

enthalten in: British journal of cancer | 2024

von Rio-Vilariño, A. | Cenigaonandia-Campillo, A. | García-Bautista, A. | +14

ErratumIn: Br J Cancer. 2024 Apr 4;:. - PMID 38575733

2

Adaptive ERK signalling activation in response to therapy and in silico prognostic evaluation of EGFR-MAPK in HNSCC

enthalten in: British journal of cancer | 2020

von Rong, C. | Muller, M. | Xiang, F. | +6

3

Nuclear IGF-1R predicts chemotherapy and targeted therapy resistance in metastatic colorectal cancer

enthalten in: British journal of cancer | 2017

von Codony-Servat, J. | Cuatrecasas, M. | Asensio, E. | +26

CommentIn: Br J Cancer. 2017 Dec 5;117(12):1733-1735. - PMID 29123265

4

Patient-reported outcomes during and after definitive chemoradiotherapy for oesophageal cancer

enthalten in: British journal of cancer | 2015

von Rees, J. | Hurt, C. | Gollins, S. | +14

5

Telomere length is a novel predictive biomarker of sensitivity to anti-EGFR therapy in metastatic colorectal cancer

enthalten in: British journal of cancer | 2015

von Augustine, T. | Baig, M. | Sood, A. | +6

6

Dasatinib worsens the effect of cetuximab in combination with fractionated radiotherapy in FaDu- and A431-derived xenografted tumours

enthalten in: British journal of cancer | 2014

von Baro, M. | de Llobet, L. | Figueras, A. | +3

7

A proposed new method for assessing the pathological response to chemotherapy in resected colorectal liver metastases

enthalten in: British journal of cancer | 2014

von Sebagh, M. | Allard, M. | Cunha, A. | +8

8

The dual PI3K/mTOR inhibitor PKI-587 enhances sensitivity to cetuximab in EGFR-resistant human head and neck cancer models

enthalten in: British journal of cancer | 2014

von D'Amato, V. | Rosa, R. | D'Amato, C. | +10

9

Serum levels of hepatocyte growth factor and epiregulin are associated with the prognosis on anti-EGFR antibody treatment in KRAS wild-type metastatic colorectal cancer

enthalten in: British journal of cancer | 2014

von Takahashi, N. | Yamada, Y. | Furuta, K. | +6

10

Epiregulin gene expression as a biomarker of benefit from cetuximab in the treatment of advanced colorectal cancer

enthalten in: British journal of cancer | 2014

von Jonker, D. | Karapetis, C. | Harbison, C. | +14

1
2
3
4
5
6
7
Nächster »
[7]